News

The U.S. Food and Drug Administration has approved Libtayo® (cemiplimab-rwlc) to treat certain types of locally advanced (cannot be removed by surgery) and metastatic (has spread) basal cell carcinoma (BCC).1...

The American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...

As the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here in the United States, it is important to...

Editor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Learn more in Self-Care in Uncertain Times...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

It is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one...

The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

The American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017...

This survey is now closed. Thank you to all our participants!We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with...

For some battling cancer, especially those with more advanced or aggressive cancers, approved or available treatment options may eventually become limited. When this happens, some may turn to clinical trials...

Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! SkinCancer.net/Health Union is teaming up with...

The U.S. Food and Drug Administration (FDA) has granted approval for Keytruda® (pembrolizumab) as a treatment for advanced or metastatic Merkel cell carcinoma in both adults and children.1Merkel cell carcinoma...

Heart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass heart disease as the number one killer in 2020, especially...

One of the biggest challenges that medical students (and even residents) face is lack of practical experience. While medical education is extensive, much of it is learned in classroom or...